期刊文献+

非对称性小RNA干扰技术介导的USP22基因沉默的研究 被引量:5

Effect of the specific asymmerytic structure interfering RNA on ubiquitin specific peptidase 22 silencing in bladder cancer EJ cells
原文传递
导出
摘要 目的 观察非对称小干扰RNA(aiRNA)对膀胱癌EJ细胞泛素特异肽酶22(USP22)基因的沉默效率及特异性的影响.方法 设计并合成USP22基因的小干扰RNA(siRNA)及aiRNA,利用脂质体Translipid转染EJ细胞,采用实时荧光定量聚合酶链反应(PCR)检测转染前后EJ细胞USP22 mRNA的表达水平变化,比较USP22 siRNA与USP22 aiRNA对USP22基因沉默效率及特异性的差异.结果 浓度为50 nmol/L的15/21 USP22 aiRNA能明显抑制EJ细胞中USP22基因mRNA的表达,转染48 h后USP22 mRNA的表达水平下降到最低[(8.30±1.68)%,P<0.05],且其沉默效率和特异性明显优于USP22 siRNA.结论 以非对称小RNA干扰技术为基础设计的USP22aiRNA能够有效沉默USP22基因,并且降低了非特异性的脱靶效应,减少了受RNA干扰中的"饱和机制"及"竞争机制"的影响,弥补了传统siRNA的一些不足. Objective To explore the effect of ubiquitin specific peptidase 22 (USP22) asymmetric structure interfering RNA (aiRNA) on USP22 gene silencing in bladder cancer EJ cells. Methods Control small interfering RNA (siRNA), the USP22-specific siRNA, and aiRNAs were designed and synthesized. The EJ cells were treated with control siRNA, USP22 siRNA or aiRNAs. The expression levels of USP22 mRNA were detected by using real-time reverse transcription-polymerase chain reaction ( RT-PCR), and the effects of the siRNA- and aiRNA-mediated silence of the target USP22 gene expression were compared. Results In contrast to USP22 siRNA, the 50 nM 15/21 USP22 aiRNA displayed the strongest inhibitory activity among these inhibitory RNAs tested. After EJ cells were treated with 15/21 USP22 aiRNA for 48 h, the expression levels of USP22 mRNA were reduced to the lowest levels[(8.30 ±1.68)% ,P〈0.05]. Conclusion The USP22 gene silencing mediated by 15/21 USP22 aiRNA was efficient, durable and reduced off-target silencing and nonspecific effects. The technology of asymmetric structure iRNA may be a novel approach for the gene research.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第10期1511-1513,共3页 Chinese Journal of Experimental Surgery
基金 基金项目:国家自然科学基金资助项目(30972980)
关键词 非对称性小干扰RNA 泛素特异肽酶22 基因沉默 asymmetric structure interfering RNA Ubiquitin specific peptidase 22 Gene silencing
  • 相关文献

参考文献9

  • 1Yao MC,Chao JL.RNA-guided DNA deletion in Tetrahymena:an RNAi-based mechanism for programmed genome rearrangements.Annu Rev Genet,2005,39:537-559.
  • 2Hannon GJ.RNA interference.Nature,2002,418:244-251.
  • 3Chang CI,Yoo JW,Hong SW,et al.Asymmetric shorter-duplex siRNA structures trigger efficient gene silencing with reduced nonspecific effects.Molecular Therapy,2009,17:725-732.
  • 4Sun X,Rogoff HA,Li CJ.Asymmetric RNA duplexes mediate RNA interference in mammalian cells.Nat Biotechnol,2008,26:1379-1382.
  • 5Sun X.The expression patterns of deubiquitinating enzymes,USP22 and Usp22.Gene Expr Patterns,2007,6:277-284.
  • 6Glinsky GV.Death-from-cancer signatures and stem cell contribution to metastatic cancer.Cell Cycle,2005,4:1171-1175.
  • 7Zhang XY,Varthi M,Sykes SM,et al.The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression.Mol Cell,2008,29:102-111.
  • 8Sano M,Sierant M,Miyagishi M,et al.Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection.Nucleic Acids Res,2008,36:5812-5821.
  • 9Chang CI,Hong SW,Kim S,et al.A structure-activity relationship study of siRNAs with structural variations.Biochem Biophys Res Commun,2007,359:997-1003.

同被引文献12

  • 1Fawzia Bardag-Gorce.Effects of ethanol on the proteasome interacting proteins[J].World Journal of Gastroenterology,2010,16(11):1349-1357. 被引量:4
  • 2吕伟,陈凛.胃癌分子靶向治疗的现状与进展[J].世界华人消化杂志,2007,15(25):2672-2678. 被引量:20
  • 3Czauderna P,Otte JB,Roebuck DJ.Comments on surgical treatment of locally advanced hepatoblastoma[J].Cancer,2012,118(16):4 092-4 093.
  • 4Lee HJ,Kim MS,Shin JM,et al.The expression patterns of deubiquitinating enzymes,USP22and Usp22[J].Gene Expr Patterns,2006,6:277-284.
  • 5Glinsky GV.“Stemness”genomics law governs clinical behavior of human cancer:Implications for decision making in disease management[J].Journal of Clinical Oncology,2008,26:2 846-2 853.
  • 6Zhao Y,Lang G,Ito S,et al.TFTC/STAGA module mediates histone H2Aand H2Bdeubiquitination,coactivates nuclear receptors and counteracts heterochromatin silencing[J].Mol Cell,2008,29:92-101.
  • 7Zhang XY,Varthi M,Sykes SM,et al.The putative cancer stem cell marker USP22is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression[J].Mol Cell,2008,29:102-111.
  • 8Henry KW,Wyce A,Lo WS,et al.Transcriptional activation via sequential histone H2Bubiquitylation and deubiquitylation,mediated by SAGA-associated Ubp8[J].Genes Dev,2003,17:2 648-2 663.
  • 9贾平,卢运萍,马丁.DNA拓扑异构酶在卵巢癌细胞拓扑替康耐药中的作用[J].华中科技大学学报(医学版),2008,37(1):69-72. 被引量:1
  • 10骆杨,曾甫清,顾朝辉,汪良,王智宇,蒋国松,肖行远.膀胱移行细胞癌中候选肿瘤干细胞标记物USP22mRNA水平定量分析及其与肿瘤分级的关系[J].临床泌尿外科杂志,2009,24(2):140-144. 被引量:7

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部